Zhejiang Zuoli Pharmaceutical Co., Ltd. announced that four of its products have been included in the National Essential Medicines List (2026 Edition), which takes effect on September 1, 2026. Bailing Capsules are newly added, while Wuling Capsules, Lingze Tablets, and Bailing Tablets continue to be included. This inclusion is expected to facilitate broader coverage in medical institutions and enhance the company's market competitiveness, though actual sales remain subject to various market factors.
Summary generated by AI · Always verify with source document
Stock Code: 300181 Stock Abbreviation: Zuoli Pharmaceutical Announcement No.: 2026-046
Zhejiang Zuoli Pharmaceutical Co., Ltd.
Announcement Regarding the Inclusion of Core Products of the Company and its Holding Subsidiary in the National Essential Medicines List (2026 Edition)
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or material omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.